sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
24-Apr-2014 00:53
US Eastern Time

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Portal: Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 801-825 out of 882.

<< < 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 > >>

Public Release: 13-Jun-2012
GAVI boosts global response to measles outbreaks
Seeking to address the devastating resurgence of measles, the GAVI Alliance will provide up to an additional $162 million to control and prevent outbreaks in developing countries. This funding will help countries bridge critical gaps in their efforts to build sustainable systems to control this deadly disease.
GAVI Alliance

Contact: Dan Thomas
dthomas@gavialliance.org
41-792-518-581
Burness Communications

Public Release: 13-Jun-2012
Journal of Medicinal Chemistry
New drug-screening method yields long-sought anti-HIV compounds
Scientists at the Scripps Research Institute have used a powerful new chemical-screening method to find compounds that inhibit the activity of human immunodeficiency virus (HIV), the virus that causes AIDS.
NIH/National Institute of General Medical Sciences, NIH/National Institute of Allergy and Infection Diseases, California HIV/AIDS Research Program, others

Contact: Mika Ono
mikaono@scripps.edu
858-784-2052
Scripps Research Institute

Public Release: 13-Jun-2012
Clinical trial of human hookworm vaccine begins at Children's National Medical Center
Today, the Sabin Vaccine Institute, in partnership with the George Washington University and the Children's National Medical Center, began vaccinating participants for a Phase 1 clinical trial of a novel human hookworm vaccine. The trial will investigate the Na-GST-1 antigen developed by the Sabin Vaccine Institute Product Development Partnership to prevent hookworm infections in endemic areas.

Contact: Johanna Harvey
Johanna.harvey@sabin.org
202-621-1691
Sabin Vaccine Institute

Public Release: 13-Jun-2012
Evolutionary Applications
Genetic discovery will help fight diarrhea outbreaks
Researchers at the University of East Anglia have discovered unexpectedly large genetic differences between two similar species of the pathogenic Cryptosporidium parasite.

Contact: Simon Dunford
s.dunford@uea.ac.uk
44-160-359-2203
University of East Anglia

Public Release: 12-Jun-2012
Health Policy & Planning
Save the Children report shows global health funding often ignores newborn babies
Save the Children's major new report, "A Decade of Change for Newborn Survival," was published in the medical journal, Health Policy and Planning today. Sixty main authors and 90 contributors collaborated for 3 years on a first-of-its-kind analysis of newborn health around the world and what is needed to speed up progress on ending newborn deaths. From 2000 to 2010 newborn deaths dropped from 3.7 million to 3.1 million annually.
Save the Children, Bill and Melinda Gates Foundation

Contact: Tanya Weinberg
tweinberg@savechildren.org
202-247-6610
Save the Children

Public Release: 12-Jun-2012
Proceedings of the National Academy of Sciences
UCI researchers create mosquitoes incapable of transmitting malaria
Mosquitoes bred to be unable to infect people with the malaria parasite are an attractive approach to helping curb one of the world's most pressing public health issues, according to UC Irvine scientists.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Tom Vasich
tmvasich@uci.edu
949-824-6455
University of California - Irvine

Public Release: 12-Jun-2012
Astellas and DNDi to collaborate on new drug discovery research for the treatment of NTDs
Astellas Pharma Inc. and the Drugs for Neglected Diseases initiative announced an agreement today to collaborate on drug discovery research for leishmaniasis, Chagas disease, and sleeping sickness -- three neglected tropical diseases (NTDs) which together affect nearly 10 million people worldwide. The agreement is a first critical step in Astellas' new strategy to enter into the field of NTDs, with DNDi as its first partner.

Contact: Violaine Daellenbach
vdallenbach@dndi.org
41-794-241-474
Drugs for Neglected Diseases Initiative

Public Release: 12-Jun-2012
Circulation
Echocardiogram screenings are effective in preventing rheumatic heart disease
Routine screening with echocardiogram can detect three times as many cases of rheumatic heart disease as clinical examinations, offering a novel approach in preventing this common disease, according to a new study in Circulation. The study, conducted by cardiologists from Children's National Medical Center, is the largest single-population study in Africa. The August issue of Nature Reviews -- Cardiology features a summary of the article in its Public Health feature.

Contact: Emily Dammeyer
edammeye@childrensnational.org
202-476-4500
Children's National Medical Center

Public Release: 12-Jun-2012
PLOS Medicine
Nevirapine based treatment for HIV is effective in African women
In African women, an anti-AIDS treatment regimen that includes the drug nevirapine is as effective as a treatment regimen with the more expensive drugs, lopinavir/ritonavir, according to a study by a team of international researchers published in this week's PLoS Medicine.

Contact: Clare Weaver
press@plos.org
44-122-344-2834
PLOS

Public Release: 11-Jun-2012
Proceedings of the National Academy of Sciences
In countries where cooking can kill, trying to promote safer stoves
Traditional cookstoves are to blame for much of the pollution that leads to millions of deaths in the developing world. Safer stoves are available, but few people buy them. Stanford researchers say that's because the newer models aren't designed to give people what they really want.
Freeman Spogli Institute for International Studies, Woods Center for the Environment, International Growth Center

Contact: Adam Gorlick
agorlick@stanford.edu
Stanford University

Public Release: 11-Jun-2012
PLOS ONE
Scientists find new genetic path to deadly diarrheal disease
Scientists have found new genetic information that shows how harmful bacteria cause the acute diarrheal disease shigellosis, which kills more than a million people worldwide each year.
National Institutes of Health, Ohio University

Contact: Andrea Gibson
gibsona@ohio.edu
740-597-2166
Ohio University

Public Release: 11-Jun-2012
Proceedings of the National Academy of Sciences
Kill the germs, spare the ears: How to create antibiotics that don't hurt hearing
The world needs new antibiotics to overcome the ever increasing resistance of disease-causing bacteria -- but it doesn't need the side effect that comes with some of the most powerful ones now available: hearing loss. Today, researchers report they have developed a new approach to designing antibiotics that kill even "superbugs" but spare the delicate sensory cells of the inner ear.
National Instiutes of Health, European Community

Contact: Kara Gavin
kegavin@umich.edu
734-764-2220
University of Michigan Health System

Public Release: 11-Jun-2012
Tetrahedron
Research could lead to new drugs for major diseases
Researchers at the University of Gothenburg, Sweden, are working to develop substances that can prevent parasites, bacteria and fungi from producing essential proteins, research that could, in the long term, lead to new drugs for several major diseases.

Contact: Itedale Namro Redwan
itedale.namro@chem.gu.se
46-031-786-9097
University of Gothenburg

Public Release: 7-Jun-2012
Report addresses challenges in implementing new diagnostic tests where they are needed most
Easy-to-use, inexpensive tests to diagnose infectious diseases are urgently needed in resource-limited countries. A new report based on an American Academy of Microbiology colloquium, "Bringing the Lab to the Patient: Developing Point-of-Care Diagnostics for Resource Limited Settings," describes the challenges inherent in bringing new medical devices and technologies to the areas of the world where they are needed most.

Contact: Garth Hogan
ghogan@asmusa.org
American Society for Microbiology

Public Release: 6-Jun-2012
Pandemic preparedness
Researchers from the University of Texas at Austin and the Texas Advanced Computing Center developed the "Texas Pandemic Flu Toolkit" to assist public health officials in planning for and managing a disease outbreak. The toolkit is a web-based service that simulates the spread of pandemic flu through the state, forecasts times of peak demand, and determines where and when to place ventilators to minimize fatalities.
Texas Department of State Health Services

Contact: Faith Singer-Villalobos
faith@tacc.utexas.edu
512-232-5771
University of Texas at Austin, Texas Advanced Computing Center

Public Release: 6-Jun-2012
Nature Communications
Seasonal prevention of malaria in African children: Analysis of life-saving potential
Giving young children medicine once a month during the rainy season to protect them against malaria could prevent tens of thousands of deaths each year in some areas of Africa, according to new research.

Contact: Paula Fentiman
paula.fentiman@lshtm.ac.uk
44-207-927-2802
London School of Hygiene & Tropical Medicine

Public Release: 5-Jun-2012
Nutrition in Clinical Practice
Complex world of microbes fine-tune body weight
Researcher Rosa Krajmalnik-Brown and her colleagues at the Swette Center for Environmental Biotechnology at Arizona State University's Biodesign Institute in collaboration with John DiBaise from the Division of Gastroenterology at the Mayo Clinic, review the role of gut microbes in nutrient absorption and energy regulation.

Contact: Joseph Caspermeyer
Joseph.Caspermeyer@asu.edu
Arizona State University

Public Release: 5-Jun-2012
Scientists work together to achieve milestone against deadly diseases
Investigators at the Center for Structural Genomics of Infectious Diseases and the Seattle Structural Genomics Center for Infectious Disease reached a significant milestone by determining 1,000 protein structures from infectious disease organisms. The knowledge gained from these structures should lead to new interventions for the deadly diseases caused by these pathogens.
NIH/National Institute of Allergy and Infectious Diseases, National Institutes of Health, US Department of Health and Human Services

Contact: Jennifer Mortensen
jennifer.mortensen@seattlebiomed.org
206-256-7220
Seattle Biomedical Research Institute

Public Release: 5-Jun-2012
UBC drug formulation receives $1.1 million for clinical development as HIV treatment
A drug delivery system developed through the University of British Columbia's Neglected Global Diseases Initiative and licensed to iCo Therapeutics Inc. will receive $1.1 million from the National Research Council of Canada for clinical development as a treatment for HIV patients.
National Research Council of Canada

Contact: Prof. Kishor Wasan
kishor.wasan@ubc.ca
604-454-4864
University of British Columbia

Public Release: 4-Jun-2012
Proceedings of the National Academy of Sciences
New technology improves malaria control and vaccine development
A new technique that accurately determines the risk of infants in endemic countries developing clinical malaria could provide a valuable tool for evaluating new malaria prevention strategies and vaccines. The technique could even help to understand how anti-malarial vaccine and treatment strategies act to reduce malaria, say researchers from the Walter and Eliza Hall Institute, Swiss Tropical and Public Health Institute, University of Basel and the Papua New Guinea Institute of Medical Research.
Swiss National Science Foundation, National Institutes of Health, Victorian Government

Contact: Liz Williams
williams@wehi.edu.au
61-405-279-095
Walter and Eliza Hall Institute

Public Release: 3-Jun-2012
Griffith University tackles deadly Hendra virus
Australian medical researchers are on the brink of an effective human treatment for the deadly Hendra virus, and potentially the closely related Nipah virus, which has killed more than 200 people in South East Asia. Associate Professor Nigel McMillan from Griffith University's School of Medical Science has been awarded Australian Federal Government funding to make further progress towards a human cure for Hendra virus. Currently there are no safe, effective treatment options.
Autralian Government

Contact: Helen Wright
helen.wright@griffith.edu.au
61-047-840-6565
Griffith University

Public Release: 31-May-2012
Reproductive Health Matters
Reproductive Health Matters addresses gap policy and practice maternal health and mortality
As the UN Special Rapporteur on maternal mortality in India points out there is a "yawning gulf between ... commendable maternal mortality policies and their urgent, focused, sustained, systematic and effective implementation," the May issue of Reproductive Health Matters explores the causes and impact of this gap, but also highlights hopeful signs of progress.

Contact: Lisa Hallgarten
lhallgarten@rhmjournal.org.uk
44-207-267-6567
Elsevier

Public Release: 31-May-2012
Hepatology
Prevalence of chronic hepatitis B may exceed 2 million, higher in US than previously reported
The prevalence of chronic hepatitis B virus (HBV) infection in the US may be as high as 2.2 million cases according to a new study now available in Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases. Findings suggest the higher prevalence of chronic HBV can be attributed to foreign-born persons who were infected in their country of origin prior to arrival in the US.

Contact: Dawn Peters
healthnews@wiley.com
781-388-8408
Wiley

Public Release: 31-May-2012
Physics to tackle how food is cooked in future
In this month's Physics World, Sidney Perkowitz, Candler Professor of Physics Emeritus at Emory University, explains how applied physics led to the innovation of flameless cooking in the late 19th century and addresses the challenge of feeding a rapidly growing population in a cleaner, more efficient way.

Contact: Michael Bishop
michael.bishop@iop.org
44-117-930-1032
Institute of Physics

Public Release: 31-May-2012
PLOS ONE
Weather patterns can be used to forecast rotavirus outbreaks
By correlating weather factors like temperature, rain, and snowfall, Elena Naumova, Ph.D., professor of civil and environmental engineering at Tufts School of Engineering, is able to predict the timing and intensity of rotavirus, a disease that causes extreme diarrhea, dehydration and thousands of death annually, particularly among children. Her research focused on one of the hardest-hit regions of the world, South Asia.
NIH/National Institute of Environmental Health Sciences, National Institutes of Health, FIC Global Infectious Disease Research Training, others

Contact: Alex Reid
Alexander.Reid@tufts.edu
617-627-4173
Tufts University

Showing releases 801-825 out of 882.

<< < 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 > >>